English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 15, 2025

FDA proposes reducing nicotine levels in combusted tobacco products
+ Pharmaceuticals
Patient Daily | Jan 14, 2025

Mayo Clinic partners with Microsoft and Cerebras for AI advancements in healthcare
+ Pharmaceuticals
Patient Daily | Jan 14, 2025

UTHealth Houston study examines risks for children born to young male cancer survivors
+ Regulatory
Patient Daily reports | Jan 14, 2025

National health reform group: 'Plenty of evidence that hospitals are not passing along' discounted drug prices under 340b program
+ Pharmaceuticals
Patient Daily | Jan 13, 2025

Higher norovirus outbreaks prompt prevention advice from health experts
+ Pharmaceuticals
Patient Daily | Jan 13, 2025

Lung association urges Connecticut residents to test homes for radon
+ Pharmaceuticals
Patient Daily | Jan 13, 2025

Mayo Clinic introduces digital pathology platform with support from NVIDIA
+ Regulatory
Patient Daily News Service | Jan 12, 2025

National Consumers League CEO: Federal 340b drug discount program ‘hijacked by hospitals and contract pharmacies’

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones